In the face of abrupt weight loss, one of the most common consequences is hair loss, even after bariatric surgery. Losing ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...

Eli Lilly's tirzepatide has been shown to significantly ... over the weekend and simultaneously published in the New England Journal of Medicine – also showed that treatment with the dual ...

If you continue to have this issue please contact [email protected]. Adults receiving tirzepatide in the SURPASS trials had significant decreases in urine albumin-to-creatinine ratio.

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...

Tirzepatide, the active ingredient in ... according to research published Jan. 29 in The New England Journal of Medicine. Congenital generalized lipodystrophy — a disorder that significantly ...

Zepbound (tirzepatide) is only available on prescription for people with obesity, or those with overweight. Learn how to get Zepbound online, in-person, and through the drug’s manufacturer ...

The FDA is about to make it a lot harder to get cheap weight-loss drugs Jessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life ...

Researchers from the Rutgers Robert Wood Johnson Medical School and the Children's Hospital of Orange County discovered a ...